• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Oct7
Citius Oncology Establishes International Access for LYMPHIR™ in Southern Europe
12:48
Aug13
Citius Oncology released FY2025 9 Months Earnings on August 12, 2025 (EST) with actual revenue of USD 0 and EPS of USD -0.2762
03:00
Citius Oncology released FY2025 Q3 earnings on August 12 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.0799 (forecast USD -0.15)
03:00
Jul17
Citius Oncology Completes $9 Million Public Offering
22:35
Jul15
Citius Oncology Signs Distribution Agreement to Enhance LYMPHIR Commercial Infrastructure
12:35
Jul14
Citius Oncology Announces Equity Offering Plan, Stock Price Dropped
14:59

Schedules & Filings

Schedules
Filings
Aug12
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -5.37 M, EPS -0.075

May14
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -7.736 M, EPS -0.1081

Feb14
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -6.659 M, EPS -0.093

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
AFJK
88.500
+1,006.25%
+80.500
OCG
10.270
+291.98%
+7.650
NCPL
1.400
+112.48%
+0.741
LGHL
8.050
+85.91%
+3.720
JXG
8.630
+67.90%
+3.490
ATMVR
1.060
+49.49%
+0.351
DBI
7.200
+48.45%
+2.350
HSPO
17.500
+42.28%
+5.200
CYPH
1.620
+39.66%
+0.460
ALEX
20.850
+37.71%
+5.710
View More